Market

ASTRAZENECA PHARMA INDIA LTD.

  • NSE CodeASTRAZENEQ
  • BSE Code506820
  • ISININE203A01020
  • IndustryPharmaceuticals


Company Information

Management

Ms. Manasa Rama

Co. Secretary & Compl. Officer

Ms. Bhavana Agrawal

Chief Financial Officer

Incorporation Year

11/07/1979

Registered Address

Registered & Corporate Office : Block N1, 12th Floor, , Manyata Embassy Business Park, , Rachenahalli, Outer Ring Road,
Bengaluru, Karnataka - 560045
Tel: 080-67748000
Fax: 080-67748557

Registrar Office

Integrated Registry Management Services Pvt. Ltd.
#30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram
Bengaluru,560003,Karnataka
Tel: 080-23460815-818
Fax: 23460819

Email

comp.secy@astrazeneca.com

Website

http://www.astrazeneca.com/india

Listing

BSE, BSE, BSE, MCXSX, NSE, NSE

Corporate News

AstraZeneca Pharma I - Launch Of Eculizumab (Soliris)

06-Aug-2025|3:03PM

Please find the enclosed intimation of the Company in relation to the capti

AstraZeneca Pharma I - Updates

06-Aug-2025|3:00PM

AstraZeneca Pharma India Limited has informed the Exchange regarding 'Launc

AstraZeneca Pharma I - News Verification

01-Aug-2025|7:10PM

The Exchange has sought clarification from AstraZeneca Pharma India Limited

AstraZeneca Pharma I - Clarification On News Item App...

01-Aug-2025|7:06PM

Please find the enclosed letter of the Company in relation to the captioned

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug66.84189.52
Aarti Drug491.754,488.20
Aarti Pharma846.257,669.96
Abbott India32,845.0069,793.33
Accent Micro299.20717.75

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Nippon India ..586.250.88
Bandhan Innov..59.643.70
Nippon India ..55.740.65
ICICI Prudent..49.020.86
Baroda BNP Pa..30.472.30

Board Meetings

DatePurpose
14/08/2025Quarterly Results
30/05/2025Audited Results & D..
11/02/2025Quarterly Results
13/11/2024Quarterly Results
08/08/2024Quarterly Results